[go: up one dir, main page]

MX9304767A - Antigeno de malaria pfemp3, analogos, anticuerpos y usos de los mismos. - Google Patents

Antigeno de malaria pfemp3, analogos, anticuerpos y usos de los mismos.

Info

Publication number
MX9304767A
MX9304767A MX9304767A MX9304767A MX9304767A MX 9304767 A MX9304767 A MX 9304767A MX 9304767 A MX9304767 A MX 9304767A MX 9304767 A MX9304767 A MX 9304767A MX 9304767 A MX9304767 A MX 9304767A
Authority
MX
Mexico
Prior art keywords
pfemp3
malaria
antibodies
analogs
antigen
Prior art date
Application number
MX9304767A
Other languages
English (en)
Inventor
Marie R Van Schravendijk
Shiroma M Handunnetti
Russel J Howard
Brittan L Pasloske
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MX9304767A publication Critical patent/MX9304767A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Un péptido designado PfEMP3, de la superficie de los parásitos de malaria es el que se expone. Los anticuerpos monoclonales que reconocen a éste y a otras proteínas de gran superficie encontrados en los eritrocitos parasitados, también se proporcionan, junto con los ácidos nucleicos que codifican para la proteína del parásito. También se exponen métodos para utilizarse en el diagnóstico y tratamiento de la infección de malaria.
MX9304767A 1992-08-07 1993-08-05 Antigeno de malaria pfemp3, analogos, anticuerpos y usos de los mismos. MX9304767A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US92753192A 1992-08-07 1992-08-07

Publications (1)

Publication Number Publication Date
MX9304767A true MX9304767A (es) 1994-02-28

Family

ID=25454864

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9304767A MX9304767A (es) 1992-08-07 1993-08-05 Antigeno de malaria pfemp3, analogos, anticuerpos y usos de los mismos.

Country Status (4)

Country Link
CN (1) CN1084855A (es)
AU (1) AU4996193A (es)
MX (1) MX9304767A (es)
WO (1) WO1994003604A1 (es)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996033736A1 (en) * 1995-04-27 1996-10-31 Affymax Technologies N.V. Malaria peptides and vaccines

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3831351A1 (de) * 1987-12-30 1989-07-13 Behringwerke Ag Malaria-spezifische dna-sequenzen, ihre expressionsprodukte und deren verwendung

Also Published As

Publication number Publication date
AU4996193A (en) 1994-03-03
WO1994003604A1 (en) 1994-02-17
CN1084855A (zh) 1994-04-06

Similar Documents

Publication Publication Date Title
FI882173A7 (fi) Synteettinen peptidiantigeeni HIV-2-tartunnan toteamiseksi.
ES2109254T3 (es) Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
DK200189D0 (da) Hiv-env-kodet peptid, der kan udvaelge hiv-inhiberende antistoffer hos pattedyr
CL2009002139A1 (es) Peptido sintetico que comprende la secuencia sec id no:6 y sec id no:7 de la proteina gp41 del virus vih con actividad antiretroviral.
ATE109795T1 (de) Htlv-iii umhüllende peptiden.
ATE110047T1 (de) Verfahren zur oligomerisierung von olefinen.
FI881418A7 (fi) Synteettiset peptidiantigeenit HIV-1 -infektion toteamiseksi.
DK532284A (da) Fremgangsmaade til bestemmelse af antigenaktive aminosyresekvenser
DK0644202T3 (da) Syntetiske antigener til påvisning af antistoffer imod hepatitis C virus
DE3872754D1 (de) Nachweis von antikoerpern humaner immundefizienz-viren.
ES548617A0 (es) Procedimiento para disociar peptidos y proteinas en el enla-ce metionilo
IT1197625B (it) Antigene di picornavirus sintetico
IT8319160A0 (it) Procedimento di sintesi di peptidi e agenti di bloccaggio di amminoacidi.
DE69230917D1 (de) Verfahren zur detektion von hepatitis c
YU48525B (sh) Protein, dnk koji kodira protein, rekombinantni vektor koji obuhvata dnk i postupak za proizovodnju proteina
DE68906566D1 (de) Dimerisierung von niedrigen alpha-olefinen.
DE3871318D1 (de) Oligomerisation von olefinen.
DE3876213D1 (de) Dimerisierung von acrylnitril.
MX9304767A (es) Antigeno de malaria pfemp3, analogos, anticuerpos y usos de los mismos.
KR890700683A (ko) 인체 면역 결핍 바이러스에 대한 항체 검색 방법
FI883585L (fi) Menetelmä verihiutalesolun pinta-antigeenin läsnäolon toteamiseksi
DK218886D0 (da) Tvaerreaktive og beskyttende epitoper af circumsporozoit-proteiner
DK36988D0 (da) Ekspression af p.falciparum-circumsporozoitprotein af gaer
DE68919697D1 (de) Katalytische hydrofluorierung von alkenen.
ES2037795T3 (es) Procedimiento para la preparacion del antigeno hrpii de plasmodium falciparum sge2.